Searched for
DRUG PRICING INDIA
Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller
- Drug cos refuse to take sole responsibility for overpricing
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...03 Sep, 2026, 09.16 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...03 Sep, 2026, 11.55 AM IST
- Stocks in news: Swiggy, Adani Ports, IDFC First Bank, Hexaware Technologies and Sun PharmaIndian markets experienced a sharp decline on Wednesday due to global factors. Technical analysis suggests further downside potential for t...03 Sep, 2026, 09.31 AM IST
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...02 Sep, 2026, 09.02 AM IST
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...01 Sep, 2026, 10.26 AM IST
- Symbiotec Pharmalab shares list at 1% discount to IPO priceThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...01 Sep, 2026, 10.08 AM IST
- Stocks in news: HDFC Bank, Ola Electric Mobility, NBCC and Knowledge Realty TrustIndian equity markets closed higher on Friday, ending a losing streak with IT stock gains. HDFC Bank's CEO will not seek reappointment, whi...31 Aug, 2026, 06.00 AM IST
- India's aviation boom faces turbulence amid safety concernsIndia's airline sector faces significant safety and financial challenges. Recent incidents have exposed regulatory and operational shortcom...30 Aug, 2026, 09.57 AM IST
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...30 Aug, 2026, 07.01 AM IST
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...27 Aug, 2026, 07.17 PM IST
- School assembly news headlines, August 27: National, international, business, sports and education headlines for studentsSchool assembly news headlines, August 27: Floods in Nepal have caused fatalities and missing persons, prompting humanitarian aid from Indi...26 Aug, 2026, 06.34 PM IST
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...26 Aug, 2026, 06.21 PM IST
- Stocks in news: Groww, Tata Motors PV, Cipla, Varun Beverages and Axis BankThe Indian equity market experienced a positive turnaround on Tuesday, August 25, highlighted by the Nifty 50 making a robust recovery. Ant...26 Aug, 2026, 06.00 AM IST
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...24 Aug, 2026, 11.49 AM IST
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...24 Aug, 2026, 11.04 AM IST
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...24 Aug, 2026, 08.08 AM IST
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...21 Aug, 2026, 09.21 PM IST
Load More
